Cacti Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Cacti Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1M	Hold	36,450	–	–	0.11%	44
2026 Q1	$2.21M	Hold	36,450	–	–	0.13%	42
2025 Q4	$1.97M	Hold	36,450	–	–	0.12%	41
2025 Q3	$1.61M	Hold	36,450	–	–	0.11%	44
2025 Q2	$1.69M	Hold	36,450	–	–	0.12%	46
2025 Q1	$2.19M	Hold	36,450	–	–	0.17%	40
2024 Q4	$2.04M	Hold	36,450	–	–	0.15%	40
2024 Q3	$1.86M	Hold	36,450	–	–	0.14%	43
2024 Q2	$1.51M	Hold	36,450	–	–	0.12%	44
2024 Q1	$1.5M	Hold	36,450	–	–	0.12%	45
2023 Q4	$1.87M	Hold	36,450	–	–	0.16%	40
2023 Q3	$2.11M	Hold	36,450	–	–	0.2%	36
2023 Q2	$2.33M	Hold	36,450	–	–	0.21%	34
2023 Q1	$2.53M	Buy	36,450 +500	+1%	+$35.3K	0.23%	32
2022 Q4	$2.59M	Hold	35,950	–	–	0.24%	31
2022 Q3	$2.56M	Hold	35,950	–	–	0.26%	30
2022 Q2	$2.77M	Hold	35,950	–	–	0.26%	31
2022 Q1	$2.63M	Hold	35,950	–	–	0.2%	34
2021 Q4	$2.24M	Hold	35,950	–	–	0.17%	37
2021 Q3	$2.13M	Hold	35,950	–	–	0.18%	40
2021 Q2	$2.4M	Hold	35,950	–	–	0.19%	36
2021 Q1	$2.27M	Sell	35,950 -14,500	-29%	-$902K	0.2%	35
2020 Q4	$2.24M	Hold	50,450	–	–	0.22%	35
2020 Q3	$2.18M	Hold	50,450	–	–	0.25%	33
2020 Q2	$2.07M	Buy	50,450 +500	+1%	+$29.9K	0.24%	32
2020 Q1	$1.99M	Sell	49,950 -40,500	-45%	-$2.48M	0.23%	29
2019 Q4	$3.28M	Buy	90,450 +59,000	+188%	+$3.38M	0.24%	30
2019 Q3	$1.59M	Buy	31,450 +570	+2%	+$26.8K	0.12%	38
2019 Q2	$1.39M	Sell	30,880 -600	-2%	-$27.9K	0.11%	43
2019 Q1	$1.5M	Hold	31,480	–	–	0.12%	39
2018 Q4	$1.64M	Hold	31,480	–	–	0.14%	37
2018 Q3	$1.95M	Sell	31,480 -1,500	-5%	-$89K	0.14%	37
2018 Q2	$1.82M	Hold	32,980	–	–	0.15%	37
2018 Q1	$2.06M	Buy	32,980 +300	+0.9%	+$19.3K	0.17%	35
2017 Q4	$2M	Hold	32,680	–	–	0.16%	38
2017 Q3	$2.06M	Hold	32,680	–	–	0.17%	38
2017 Q2	$1.82M	Hold	32,680	–	–	0.16%	41
2017 Q1	$1.81M	Hold	32,680	–	–	0.16%	39
2016 Q4	$1.91M	Hold	32,680	–	–	0.18%	39
2016 Q3	$1.76M	Hold	32,680	–	–	0.18%	37
2016 Q2	$2.4M	Hold	32,680	–	–	0.26%	38
2016 Q1	$2.07M	Hold	32,680	–	–	0.22%	39
2015 Q4	$2.25M	Hold	32,680	–	–	0.24%	38
2015 Q3	$1.94M	Hold	32,680	–	–	0.22%	39
2015 Q2	$2.17M	Hold	32,680	–	–	0.23%	38
2015 Q1	$2.11M	Hold	32,680	–	–	0.22%	38
2014 Q4	$1.93M	Hold	32,680	–	–	0.22%	37
2014 Q3	$1.67M	Hold	32,680	–	–	0.2%	38
2014 Q2	$1.6M	Hold	32,680	–	–	0.2%	40
2014 Q1	$1.7M	Hold	32,680	–	–	0.23%	38
2013 Q4	$1.74M	Hold	32,680	–	–	0.26%	37
2013 Q3	$1.51M	Sell	32,680 -500	-2%	-$21.9K	0.26%	36
2013 Q2	$1.48M	Buy	+33,180	New	+$1.44M	0.28%	36

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Cacti Asset Management's BMY Position: Q2 2026 in Review

Cacti Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 36,450 shares worth $2.1M. The position accounts for 0.11% of the portfolio, ranked #44.

Cacti Asset Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.28M in Q4 2019. 943 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Cacti Asset Management held 36,450 shares of Bristol-Myers Squibb worth $2.1M as of Q2 2026.
Cacti Asset Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.11% of Cacti Asset Management's portfolio in Q2 2026, its #44 holding.
Cacti Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Cacti Asset Management's Bristol-Myers Squibb position peaked at $3.28M in Q4 2019.
943 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cacti Asset Management's 13F filing for Q2 2026, filed 1 Jul 2026.